Royal Bank of Canada
CUE icon

Royal Bank of Canada’s Cue Biopharma CUE Stock Holding History

Royal Bank of Canada’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+3
New +$28 ﹤0.01% 7212
2024
Q3 		– Sell
-5
Closed – – 6947
2024
Q2 		$0 Sell
5
-28
-85% -$1.39K ﹤0.01% 7128
2024
Q1 		$2K Sell
33
-382
-92% -$26.9K ﹤0.01% 6657
2023
Q4 		$33K Buy
415
+71
+21% +$5.08K ﹤0.01% 6151
2023
Q3 		$24K Buy
344
+272
+378% +$26.6K ﹤0.01% 6111
2023
Q2 		$8K Buy
+72
New +$8.46K ﹤0.01% 6531
2022
Q4 		– Sell
-7
Closed – – 7299
2022
Q3 		$0 Buy
7
+6
+600% +$516 ﹤0.01% 7500
2022
Q2 		$0 Sell
1
-88
-99% -$10.3K ﹤0.01% 7417
2022
Q1 		$13K Sell
89
-134
-60% -$28.4K ﹤0.01% 6829
2021
Q4 		$76K Buy
223
+128
+135% +$49.5K ﹤0.01% 6122
2021
Q3 		$42K Buy
95
+27
+40% +$9.42K ﹤0.01% 6258
2021
Q2 		$24K Sell
68
-6
-8% -$2.33K ﹤0.01% 6466
2021
Q1 		$27K Buy
74
+67
+957% +$27.6K ﹤0.01% 6247
2020
Q4 		$3K Buy
7
+5
+250% +$2K ﹤0.01% 6786
2020
Q3 		$1K Buy
2
+1
+100% +$576 ﹤0.01% 6408
2020
Q2 		$1K Sell
1
-3
-75% -$2.17K ﹤0.01% 6403
2020
Q1 		$2K Sell
4
-51
-93% -$24.7K ﹤0.01% 6280
2019
Q4 		$26K Buy
+55
New +$17.3K ﹤0.01% 5739
2018
Q4 		– Sell
-94
Closed -$26K – 6810
2018
Q3 		$26K Sell
94
-50
-35% -$14.4K ﹤0.01% 5542
2018
Q2 		$52K Buy
+144
New +$57.2K ﹤0.01% 5143

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Royal Bank of Canada's CUE Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Cue Biopharma (CUE) in Q1 2026: 3 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7212 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in CUE as recently as Q2 2024.

Royal Bank of Canada first reported a position in CUE in Q2 2018 and has held it in 20 quarters since. The position peaked at $76K in Q4 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Royal Bank of Canada held 3 shares of Cue Biopharma worth $0 as of Q1 2026.
  • Cue Biopharma was a new Royal Bank of Canada position in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7212 holding.
  • Royal Bank of Canada first reported a position in Cue Biopharma in Q2 2018 and has held it in 20 quarters since.
  • Royal Bank of Canada's Cue Biopharma position peaked at $76K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.